← Human Trials & Peer-Reviewed Studies
Effects of a 2-Year Early Childhood Vitamin D3 Intervention on Tooth Enamel and Oral Health at Age 6-7 Years.
Plain-language guide to PMID 36473453 (2023): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 975 infants.
Key Facts
- PMID
- 36473453
- Journal
- Hormone research in paediatrics
- Year
- 2023
- Study type
- Randomized Controlled Trial
- Authors
- Arponen H et al. (9 authors)
- DOI
- 10.1159/000528536
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Who Took Part
The study group was 975 infants.
By PubMed's age tags, the people studied were infants, young children and children, both men and women.
For the present follow-up study at age 6-7 years, a sample of 123 children underwent oral examination by investigators blinded to the intervention group.
How the Study Was Run
The researchers set it up as a randomized and double-blind study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Neither the infants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
Tooth enamel defect and caries findings, oral rinse active matrix metalloproteinase-8 levels, and tooth eruption were recorded.
The intervention groups were compared with χ2 and Mann-Whitney U tests.
Associations of the oral health outcomes were evaluated with correlation analysis and logistic regression.
What Was Measured
Topics PubMed links to this paper include Oral Health, Vitamin D, Cholecalciferol, Vitamins, Dental Enamel, Dietary Supplements and Vitamin A.
The authors tagged it with the keywords Matrix metalloproteinase and Molar-incisor hypomineralization.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 975 infants.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2023 (Hormone research in paediatrics), a journal based in Switzerland.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.